Inquiry Basket
Loading ......
Listeria monocytogenes is a ubiquitous, Gram-positive, facultative intracellular bacterium that has emerged as one of the most formidable foodborne pathogens of the modern era. As the causative agent of listeriosis, this microorganism represents a critical intersection of clinical microbiology, epidemiology, and industrial food safety. Unlike many traditional enteric pathogens that are effectively inhibited by standard food preservation techniques, Listeria exhibits remarkable physiological resilience. It is psychrotrophic, meaning it can survive and actively multiply at standard refrigeration temperatures. Furthermore, it demonstrates extreme tolerance to high osmotic stress, low pH environments, and varying oxygen levels. In recent years, search trends and public health discourse have heavily focused on the pathogen due to severe, multi-state, and multinational outbreaks linked to ready-to-eat (RTE) foods, including deli meats, soft cheeses, smoked seafood, and fresh produce. The enduring challenge of Listeria in the food supply chain, combined with its exceptionally high clinical mortality rate among vulnerable populations, makes understanding its biological mechanisms and epidemiological dynamics a top priority for global health authorities and the food production industry.
The epidemiology of Listeria monocytogenes is characterized by a low incidence rate but a disproportionately high rate of hospitalization and mortality, often exceeding twenty to thirty percent in invasive cases. The pathogen is widespread in natural environments, commonly isolated from soil, decaying vegetation, and water sources, which serve as the primary reservoirs for agricultural contamination. From these environments, the bacteria can infiltrate food processing facilities, where they are notoriously difficult to eradicate.
In the past decade, the landscape of outbreak investigation and epidemiological tracking has been entirely revolutionized by the implementation of Whole-Genome Sequencing (WGS). Modern public health surveillance networks routinely utilize WGS to analyze clinical isolates alongside environmental and food isolates. This highly sensitive genomic approach provides unparalleled resolution, allowing epidemiologists to detect related clusters of illness that are geographically dispersed and temporally separated. By identifying specific single nucleotide polymorphisms (SNPs) and mapping the precise genetic lineage of the bacterial strains, health agencies can now definitively trace a sporadic human infection back to a specific piece of equipment in a specific processing facility, even months after the initial contamination event. This technological leap has significantly increased the detection of outbreaks and has become a focal point in modern food safety litigation and regulatory compliance.
Figure 1. Minimum spanning tree constructed based on MLST allelic profiles of 23 Listeria monocytogenes isolates.
(Source: Lee SH, et al. 2023)
The exceptional virulence of Listeria monocytogenes is fundamentally tied to its sophisticated intracellular life cycle. Upon ingestion of contaminated food, the bacteria must first survive the extreme acidity of the human stomach and the harsh luminal environment of the gastrointestinal tract. This survival is mediated by the Glutamate Decarboxylase (GAD) system and the upregulation of stress response proteins controlled by the alternative sigma factor, Sigma B.
Once the bacteria reach the lumen of the small intestine, the invasion process begins. Listeria actively induces its own phagocytosis into normally non-phagocytic cells, such as the enterocytes of the intestinal epithelium. This entry is highly specific and is driven by two primary bacterial surface proteins: Internalin A (InlA) and Internalin B (InlB). InlA binds to E-cadherin, a transmembrane cell adhesion molecule expressed on the surface of human epithelial cells, while InlB interacts with the hepatocyte growth factor receptor, c-Met. These interactions trigger localized host cytoskeletal rearrangements, resulting in the engulfment of the bacterium into a membrane-bound vacuole known as the phagosome.
To establish a productive infection, Listeria must rapidly escape this vacuole before it fuses with a lysosome, which would result in bacterial degradation. This critical escape is orchestrated by the secretion of Listeriolysin O (LLO), a potent, cholesterol-dependent cytolysin, along with two phospholipases (PlcA and PlcB). LLO forms distinct pores in the phagosomal membrane, specifically functioning optimally at the acidic pH found within the maturing vacuole, thereby preventing premature activation in the host cytosol.
Upon escaping into the host cell's nutrient-rich cytosol, the bacteria undergo rapid multiplication. Simultaneously, they initiate a remarkable mechanism of actin-based motility. The bacterial surface protein ActA acts as a biomimetic of the host's Wiskott-Aldrich syndrome protein (WASP). ActA recruits the host's Arp2/3 complex to the bacterial pole, stimulating the continuous polymerization of host actin filaments. This explosive assembly of actin forms a structural "comet tail" that propels the bacterium through the cytosol at high speeds. When the propelled bacterium impacts the host cell membrane, it forms elongated protrusions, or "listeriopods," that push into adjacent, uninfected host cells. The neighboring cell engulfs this protrusion, creating a double-membrane vacuole from which the bacterium must once again escape using LLO and phospholipases. This ingenious mechanism allows Listeria to disseminate rapidly from cell to cell, crossing critical anatomical barriers without ever entering the extracellular space, thereby effectively evading detection and neutralization by circulating host antibodies.
Figure 2. L. monocytogenes intracellular life cycle
(Source: Luque-Sastre L, et al. 2018)
The clinical presentation of Listeria infection varies drastically depending on the infectious dose, the virulence of the specific strain, and, most importantly, the immunological status of the host. In healthy, immunocompetent adults, exposure typically results in either asymptomatic carriage or a mild, self-limiting acute febrile gastroenteritis. However, the pathogen's ability to cross three critical physiological barriers—the intestinal barrier, the blood-brain barrier, and the materno-fetal barrier—leads to severe invasive listeriosis in specific high-risk cohorts.
Immunocompromised individuals, the elderly, and patients with underlying malignancies or chronic hepatic diseases are highly susceptible to severe systemic infections. In these populations, the bacteria can breach the intestinal epithelium and disseminate hematogenously, leading to life-threatening primary bacteremia and meningoencephalitis. Listeria meningitis is particularly devastating and is frequently associated with rhombencephalitis (infection of the brainstem), which presents with distinct neurological deficits, cranial nerve palsies, and a significantly higher mortality rate than meningitis caused by other bacterial pathogens.
Perhaps the most tragic clinical manifestation of invasive listeriosis occurs during pregnancy. Pregnant women are estimated to be at a substantially higher risk of infection compared to the general population due to a natural, localized dampening of cell-mediated immunity at the maternal-fetal interface. While the pregnant individual may only experience mild, flu-like symptoms, the bacteria exhibit a strong tropism for the placenta. Upon crossing the materno-fetal barrier, Listeria rapidly replicates in the immunologically privileged environment of the fetus, leading to catastrophic outcomes including spontaneous abortion, severe premature labor, stillbirth, or the delivery of an infant with neonatal listeriosis (granulomatosis infantiseptica), a disseminated and often fatal condition.
Figure 3. At the placental barrier, L. monocytogenes can invade the placenta via direct invasion of syncytiotrophoblasts (SYN)
(Source: Lamond NM, et al. 2018)
Public concern regarding Listeria is its remarkable ability to establish long-term residency within food manufacturing facilities. This persistence is primarily facilitated by the formation of complex biofilms. Biofilms are dense communities of bacteria encapsulated within a self-produced extracellular polymeric substance (EPS) matrix. When Listeria adheres to industrial surfaces such as stainless steel, conveyor belts, and floor drains, it transitions from a planktonic (free-floating) state to a sessile, biofilm-associated lifestyle.
Within these microscopic fortresses, the bacteria are highly shielded from environmental stressors, desiccation, and standard sanitation protocols. The EPS matrix acts as a physical and chemical barrier, significantly reducing the efficacy of routinely used biocides and disinfectants. Furthermore, bacteria within the deepest layers of the biofilm often enter a dormant, metabolically inactive state, rendering them inherently tolerant to many antimicrobial agents that target active cellular processes. As the biofilm matures, pieces can periodically detach, shedding infectious bacteria onto food products traveling along the production line, leading to intermittent, low-level contamination that is exceedingly difficult to detect during standard quality assurance swabbing.
Looking forward, the mitigation of Listeria monocytogenes will require highly integrated, multidisciplinary approaches. Climate change and the globalization of the food supply chain are introducing new variables, altering the geographic distribution of agricultural reservoirs and extending the transit times of perishable goods. The food industry is continuously researching novel intervention strategies, including the application of specific bacteriophages (viruses that infect and destroy bacteria) directly onto ready-to-eat foods as a targeted bio-control measure. Additionally, advancements in hygienic equipment design, predictive microbiology modeling, and the continuous refinement of WGS-based surveillance will remain the critical pillars of defense. Understanding the intricate molecular dance between this highly adapted intracellular pathogen and its host is essential for developing the next generation of therapeutics and ensuring the safety of the global food system.
References
| Target | Cat. No. | Product Name | Expression System | Tag/Conjugate | Application | |
| L. monocytogenes | DAGP0192 | Recombinant Listeria monocytogenes p60 [His] | E. coli | His | ELISA, LF | Inquiry |
| DAG-P2785 | Active Listeriolysin (aa 26 - 529) | E. coli | Unconjugated | SDS-PAGE | Inquiry | |
| DAG-P2903 | Active Listeriolysin (aa 60 - 529) | E. coli | Unconjugated | SDS-PAGE | Inquiry | |
| DAG4326 | Recombinant L. monocytogenes Internalin [His] | E. coli | His | N/A | Inquiry | |
| L. monocytogenes FliC | DAG-H10322 | L. monocytogenes Flagellin [His] | E. coli | His | N/A | Inquiry |
Loading ......
